{"transactions":[{"id":951063,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70288,"kind":"person","name":"Lorenz Kevin","position":1,"cik":"0001772558","reported_name":"Lorenz Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common stock, par value $0.001","published_at":"2026-01-05T21:30:37.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":27322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 27,322 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2027, 2028, and 2029, subject to continued service."}],"balance_after":101009,"source":{"system":"sec-edgar","filing":"0001772558-26-000002","document":"form4-01052026_040115.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000177255826000002/form4-01052026_040115.xml","form_type":"4"}},{"id":1314437,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70288,"kind":"person","name":"Lorenz Kevin","position":1,"cik":"0001772558","reported_name":"Lorenz Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common stock, par value $0.001","published_at":"2025-01-03T21:20:09.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":49383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 49,383 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2026, 2027, and 2028, subject to continued service."}],"balance_after":73687,"source":{"system":"sec-edgar","filing":"0001415889-25-000426","document":"form4-01032025_040103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000141588925000426/form4-01032025_040103.xml","form_type":"4"}},{"id":1691994,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70288,"kind":"person","name":"Lorenz Kevin","position":1,"cik":"0001772558","reported_name":"Lorenz Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2024-01-03T21:54:05.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the \"Reverse Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split."},{"field":"shares","element":"transactionShares","label":"F2","text":"One-third of the shares will vest on each of January 1, 2025, 2026, and 2027, subject to continued service."}],"balance_after":24304,"source":{"system":"sec-edgar","filing":"0001104659-24-000913","document":"tm241755-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465924000913/tm241755-8_4seq1.xml","form_type":"4"}},{"id":2067007,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70288,"kind":"person","name":"Lorenz Kevin","position":1,"cik":"0001772558","reported_name":"Lorenz Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2023-01-05T02:25:59.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-third of the shares will vest on each of January1, 2024, 2025 and 2026, subject to continued service."}],"balance_after":314572,"source":{"system":"sec-edgar","filing":"0001104659-23-001099","document":"tm231728-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465923001099/tm231728-5_4seq1.xml","form_type":"4"}},{"id":2287832,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70288,"kind":"person","name":"Lorenz Kevin","position":1,"cik":"0001772558","reported_name":"Lorenz Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2022-04-29T20:20:35.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-third of the shares will vest on each of January 1, 2023, 2024 and 2025, subject to continued service."}],"balance_after":264572,"source":{"system":"sec-edgar","filing":"0001104659-22-053584","document":"tm2213913-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465922053584/tm2213913-5_4seq1.xml","form_type":"4"}},{"id":2752040,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70288,"kind":"person","name":"Lorenz Kevin","position":1,"cik":"0001772558","reported_name":"Lorenz Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2021-04-09T21:24:12.000Z","date":"2021-01-01","kind":"purchase","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-third of the shares will vest on each of January 1, 2022, 2023 and 2024, subject to continued service."}],"balance_after":214582,"source":{"system":"sec-edgar","filing":"0001104659-21-048828","document":"tm219139d5_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465921048828/tm219139d5_4.xml","form_type":"4"}},{"id":3210909,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":70288,"kind":"person","name":"Lorenz Kevin","position":1,"cik":"0001772558","reported_name":"Lorenz Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2020-03-13T20:07:45.000Z","date":"2020-01-01","kind":"purchase","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One-third of the shares will vest on each of January 1, 2021, 2022 and 2023, subject to continued service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 34,582 shares owned by Mr. Lorenz prior to his appointment to the Company's board in August 2019."}],"balance_after":164582,"source":{"system":"sec-edgar","filing":"0001104659-20-033114","document":"tm2011481-5_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465920033114/tm2011481-5_form4.xml","form_type":"4"}}]}